Evidence map›Paper›PMID 34027814›Full record

ArticleSubstance use & misuse2021

How Do Clinicians of Different Specialties Perceive and Use Opioid Risk Mitigation Strategies? A Qualitative Study.

Michelle S Keller, Alma Jusufagic, Teryl K Nuckols, Jack Needleman, MarySue V Heilemann

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance use & misuse, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michelle S KellerDivision of General Internal Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.ORCID 0000-0002-8157-7586
Alma JusufagicDepartment of Health Policy and Management, Fielding School of Public Health, University of California-Los Angeles, Los Angeles, California, USA.
Teryl K NuckolsDivision of General Internal Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Jack NeedlemanDivision of Health Services Research, Cedars-Sinai Medical Center, Los Angeles, California, USA.
MarySue V HeilemannUCLA School of Nursing, University of California-Los Angeles, Los Angeles, California, USA.
Cedars-Sinai Medical Center · USUniversity of California, Los Angeles · US

Funding

UCLA Clinical and Translational Science InstituteTL1TR000121 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$2.7M
NCATS NIH HHS TL1 TR000121
6 · The paper itself

Abstract

backgroundIn response to the opioid crisis, states and health systems are encouraging clinicians to use risk mitigation strategies aimed at assessing a patient's risk for opioid misuse or abuse: opioid agreements, prescription drug monitoring programs (PDMPs), and urine drug tests (UDT).

Indexed as

Opioid-Related DisordersPrescription Drug Monitoring ProgramsAnalgesics, OpioidHumansQualitative ResearchSubstance Abuse DetectionAnalgesics, OpioidOpioidspain medicineprimary carequalitativeurine drug testing

Identifiers

PMID34027814
PMCPMC8667780
OpenAlexW3165532611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.